Sirolimus-induced posterior reversible encephalopathy.
Bodkin
Cynthia L
CL
Department of Neurology, Mayo Clinic Jacksonville, Jacksonville, FL 32224, USA. bodkin.cynthia@mayo.edu
Eidelman
Benjamin H
BH
D001488:Basilar Artery / Q000187:drug effects / Q000503:physiopathology; D020520:Brain Infarction / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D002531:Cerebellum / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology; D002536:Cerebral Arteries / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D018450:Disease Progression; D004646:Emphysema / Q000601:surgery; D005260:Female; D006261:Headache / Q000209:etiology; D006423:Hemianopsia / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000150:complications* / Q000503:physiopathology; D007166:Immunosuppressive Agents / Q000009:adverse effects; D020299:Intracranial Hemorrhage, Hypertensive / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D007680:Kidney Neoplasms / Q000601:surgery; D016040:Lung Transplantation; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009778:Occipital Lobe / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology; D020769:Posterior Cerebral Artery / Q000187:drug effects / Q000503:physiopathology; D020123:Sirolimus / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D020123:Sirolimus